What Researchers Did
Researchers measured S-100beta and neuron-specific enolase (NSE) levels in the blood of 30 carbon monoxide-poisoned patients at multiple time points to assess their utility as biochemical markers for neurological response and hyperbaric oxygen treatment indications.
What They Found
S-100beta levels were consistently high across all three analyses and showed a strong negative correlation with Glasgow Coma Scale levels (r = -0.7, -0.8; P = .00). A significant positive correlation was observed between S-100beta and carboxyhemoglobin levels at the initial hour (r = 0.4; P = .01), and S-100beta levels decreased considerably in patients receiving hyperbaric oxygen treatment, while NSE levels showed no significant change.
What This Means for Canadian Patients
S-100beta levels could potentially help Canadian clinicians evaluate the severity of carbon monoxide poisoning and guide treatment decisions, such as the need for hyperbaric oxygen therapy. This marker might also assist in differentiating carbon monoxide-related brain injury from other causes of neurological impairment in emergency settings.
Canadian Relevance
This study was conducted outside of Canada and does not have a direct Canadian connection.
Study Limitations
The study's relatively small sample size of 30 patients limits the generalizability of its findings.